HepQuant has named Richard Whitcomb to serve as chief operating officer of the Greenwood Village, CO, company. Whitcomb most recently worked for Boulder, CO, company Bioptix Diagnostics, where he was president and CEO. HepQuant has developed an experimental test to evaluate the liver in patients who have chronic liver disease.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
